Several of the mutations we identified are candidate novel ALS genes and we have highlighted the examples of SLC1A3, EEF1G, XRCC6, and PPARGC1B. Our findings have significant implications for the design of ALS disease models and therapeutics. Here, XRCC6 is linked to amyotrophic lateral sclerosis.